Integrated Wealth Concepts’s iShares Genomics Immunology and Healthcare ETF IDNA Stock Holding History

Integrated Wealth Concepts’s Portfolio IDNA Stock Details IDNA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-8,887	Closed	-$205K	–	1709
2024 Q2	$205K	Sell	8,887 -509	-5%	-$11.9K	﹤0.01%	1513
2024 Q1	$226K	Sell	9,396 -9,246	-50%	-$217K	﹤0.01%	1467
2023 Q4	$429K	Sell	18,642 -38,237	-67%	-$768K	0.01%	1068
2023 Q3	$1.16M	Sell	56,879 -9,770	-15%	-$219K	0.02%	633
2023 Q2	$1.56M	Buy	66,649 +55,773	+513%	+$1.34M	0.03%	541
2023 Q1	$253K	Buy	+10,876	New	+$272K	0.01%	1137

Other funds holding IDNA

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

WBG

Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

CCA

Clearwater Capital Advisors Hoffman Estates, Illinois $1.24B AUM 15.23% 1-Year Est. Return

CCA

Cora Capital Advisors Marlton, New Jersey $302M AUM 16.46% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return

Integrated Wealth Concepts's IDNA Position: Q3 2024 in Review

Integrated Wealth Concepts sold out of iShares Genomics Immunology and Healthcare ETF (IDNA) in Q3 2024, closing a stake of 8,887 shares — an estimated $205K sold.

Integrated Wealth Concepts first reported a position in IDNA in Q1 2023 and held it in 6 quarters. The position peaked at $1.56M in Q2 2023. 53 funds tracked by Wall St. Rank hold IDNA as of Q3 2024.

Integrated Wealth Concepts reported no remaining iShares Genomics Immunology and Healthcare ETF position as of Q3 2024 after selling out during the quarter.
Integrated Wealth Concepts sold 8,887 iShares Genomics Immunology and Healthcare ETF shares in Q3 2024, an estimated $205K.
Integrated Wealth Concepts first reported a position in iShares Genomics Immunology and Healthcare ETF in Q1 2023 and held it in 6 quarters.
Integrated Wealth Concepts's iShares Genomics Immunology and Healthcare ETF position peaked at $1.56M in Q2 2023.
53 funds tracked by Wall St. Rank held iShares Genomics Immunology and Healthcare ETF as of Q3 2024.

Based on Integrated Wealth Concepts's 13F filing for Q3 2024, filed 14 Nov 2024.